Noninvasive Evaluation of Cardiac Allograft Vasculopathy

NCT01305382 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-11-15

No results posted yet for this study

Summary

Abnormal peripheral endothelial function and alterations in circulating biomarkers that are associated with endothelial activation and inflammation correlate with angiographic evidence of cardiac allograft vasculopathy, defined as greater than 25% stenosis in a major coronary artery.

Conditions

  • Cardiac Allograft Vasculopathy

Sponsors & Collaborators

Principal Investigators

  • Monica M Colvin-Adams, MD, MS · Cardiology, University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305382 on ClinicalTrials.gov